Dina O. Abdulazim

668 total citations · 1 hit paper
27 papers, 478 citations indexed

About

Dina O. Abdulazim is a scholar working on Nephrology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Dina O. Abdulazim has authored 27 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 9 papers in Surgery and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Dina O. Abdulazim's work include Parathyroid Disorders and Treatments (13 papers), Pancreatitis Pathology and Treatment (6 papers) and Vitamin D Research Studies (5 papers). Dina O. Abdulazim is often cited by papers focused on Parathyroid Disorders and Treatments (13 papers), Pancreatitis Pathology and Treatment (6 papers) and Vitamin D Research Studies (5 papers). Dina O. Abdulazim collaborates with scholars based in Egypt, United States and Hungary. Dina O. Abdulazim's co-authors include Mona M. Salem, Usama A. Sharaf El Din, Ahmed A. Heikal, Mervat Naguib, Olfat Shaker, Ahmed Soliman, Mohamed A. Marie, Lajos Zsom, Karim Soliman and Éva Csongrádi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Advanced Research and ˜The œNephron journals/Nephron journals.

In The Last Decade

Dina O. Abdulazim

25 papers receiving 468 citations

Hit Papers

Uric acid in the pathogenesis of metabolic, renal, and ca... 2016 2026 2019 2022 2016 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review
    2016 296 citations Usama A. Sharaf El Din, Mona M. Salem et al. Journal of Advanced Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dina O. Abdulazim Egypt 8 297 128 109 77 70 27 478
Mona M. Salem Egypt 8 317 1.1× 133 1.0× 110 1.0× 78 1.0× 67 1.0× 23 500
Usama A. Sharaf El Din Egypt 9 469 1.6× 152 1.2× 157 1.4× 77 1.0× 111 1.6× 25 648
Kumiko Totsuka Japan 5 327 1.1× 130 1.0× 190 1.7× 156 2.0× 66 0.9× 7 594
Qin Lv China 9 222 0.7× 221 1.7× 134 1.2× 100 1.3× 60 0.9× 19 519
Naoyuki Otani Japan 14 210 0.7× 169 1.3× 87 0.8× 66 0.9× 81 1.2× 40 478
Zohreh Soltani United States 6 191 0.6× 93 0.7× 70 0.6× 99 1.3× 68 1.0× 7 381
Hiromichi Gotoh Japan 15 189 0.6× 81 0.6× 26 0.2× 60 0.8× 103 1.5× 45 544
Chensheng Fu China 13 270 0.9× 219 1.7× 93 0.9× 100 1.3× 96 1.4× 20 481
Steven Ing United States 12 77 0.3× 86 0.7× 58 0.5× 57 0.7× 117 1.7× 40 502
Georgios Efstratiadis Greece 13 198 0.7× 60 0.5× 24 0.2× 46 0.6× 114 1.6× 25 500

Countries citing papers authored by Dina O. Abdulazim

Since Specialization
Citations

This map shows the geographic impact of Dina O. Abdulazim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina O. Abdulazim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina O. Abdulazim more than expected).

Fields of papers citing papers by Dina O. Abdulazim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina O. Abdulazim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina O. Abdulazim. The network helps show where Dina O. Abdulazim may publish in the future.

Co-authorship network of co-authors of Dina O. Abdulazim

This figure shows the co-authorship network connecting the top 25 collaborators of Dina O. Abdulazim. A scholar is included among the top collaborators of Dina O. Abdulazim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina O. Abdulazim. Dina O. Abdulazim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdulazim, Dina O., et al.. (2024). Prevalence and predictors of fibromyalgia among Egyptian physicians: a cross-sectional study. SHILAP Revista de lepidopterología. 51(1). 1 indexed citations
2.
Abdulazim, Dina O., et al.. (2023). Pattern of non-infectious uveitis and visual outcome in a tertiary care university-based hospital: A multidisciplinary approach. The Egyptian Rheumatologist. 45(2). 165–169. 2 indexed citations
3.
Salem, Mona M., et al.. (2022). Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease. Nefrología (English Edition). 42(4). 390–403. 3 indexed citations
4.
Salem, Mona M., et al.. (2021). Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease. Nefrología. 42(4). 390–403. 7 indexed citations
5.
Abdulazim, Dina O., et al.. (2021). Serum sclerostin in acute kidney injury patients. Nefrología. 42(1). 50–55. 3 indexed citations
6.
Din, Usama A. Sharaf El, Mona M. Salem, & Dina O. Abdulazim. (2020). Time to Prevent the Development of Diabetic Nephropathy. 29(2). 161–173.
7.
Marie, Mohamed A., et al.. (2020). Serum Urate Lowering Therapy Using Allopurinol Improves Serum 25 Hydroxy Vitamin D in Stage 3-5 CKD Patients: A Pilot Study. ˜The œNephron journals/Nephron journals. 145(2). 133–136. 6 indexed citations
8.
Soliman, Ahmed, et al.. (2019). Impact of hepatitis virus infection on arterial calcification among incident hemodialysis patients. Nefrología. 40(3). 336–344. 1 indexed citations
9.
Soliman, Ahmed, et al.. (2019). Intraoperative Arterial Biopsy in Incident Hemodialysis Patients: Differences Observed. ˜The œNephron journals/Nephron journals. 143(1). 54–61. 1 indexed citations
10.
11.
Heikal, Ahmed A., et al.. (2018). Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients. Renal Failure. 40(1). 226–230. 21 indexed citations
12.
Abdulazim, Dina O., et al.. (2017). Vitamin D deficiency: an unrecognized cause of flank pain. Journal of Bone and Mineral Metabolism. 36(5). 605–608. 1 indexed citations
13.
Din, Usama A. Sharaf El, Mona M. Salem, & Dina O. Abdulazim. (2017). Diabetic nephropathy: Time to withhold development and progression - A review. Journal of Advanced Research. 8(4). 363–373. 41 indexed citations
14.
Salem, Mona M., et al.. (2017). Recent Advances in Management of Diabetic Nephropathy. 2(2). 5 indexed citations
15.
Din, Usama A. Sharaf El, Mona M. Salem, & Dina O. Abdulazim. (2017). Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review. Journal of Advanced Research. 8(3). 271–278. 10 indexed citations
16.
Abdulazim, Dina O., et al.. (2016). Arterial Calcification in Chronic Kidney Disease: Whom? When? and How to Handle?. 3(1). 1 indexed citations
17.
Din, Usama A. Sharaf El, Mona M. Salem, & Dina O. Abdulazim. (2016). Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. Journal of Advanced Research. 8(5). 537–548. 296 indexed citations breakdown →
18.
Salem, Mona M., et al.. (2016). Stop chronic kidney disease progression: Time is approaching. World Journal of Nephrology. 5(3). 258–258. 31 indexed citations
19.
Din, Usama A. Sharaf El, Mona M. Salem, & Dina O. Abdulazim. (2016). FGF23 and inflammation. World Journal of Nephrology. 6(1). 57–57. 9 indexed citations
20.
Salem, Mona M., et al.. (2016). Vascular calcification: When should we interfere in chronic kidney disease patients and how?. World Journal of Nephrology. 5(5). 398–398. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mona M. Salem Breakdown of academic impact, for papers by Usama A. Sharaf El Din Breakdown of academic impact, for papers by Kumiko Totsuka Breakdown of academic impact, for papers by Qin Lv Breakdown of academic impact, for papers by Naoyuki Otani Breakdown of academic impact, for papers by Zohreh Soltani Breakdown of academic impact, for papers by Hiromichi Gotoh Breakdown of academic impact, for papers by Chensheng Fu Breakdown of academic impact, for papers by Steven Ing Breakdown of academic impact, for papers by Georgios Efstratiadis
Rankless by CCL
2026